Abstract
Objective. To study the efficacy and tolerability of agomelatine (valdoxan) in the treatment of affective disorders developed after surgical correction of the appearance. Material and methods. We summarized 35 cases characterized by the development of ICD-10 depressive disorders after the face surgery performed to correct congenital and acquired malformations. Agomelatine was prescribed in dose 25-50 mg daily during 6 weeks. Patient's state was assessed using psychopathological method and psychometric scales. Results and conclusion. We obtained significant results demonstrating the efficacy of this drug in mild and moderate depressive disorders. Agomelatine had a favorable tolerability profile that provided a high level of compliance of the patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
